Sara Bianchetti

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Guy Jérusalem, Gabriella Mariani, Eva Ciruelos et al. · Annals of Oncology · 2016 · 72 citations · Full text

Endocrine Oncology, Metastatic Breast Cancer, Breast Oncology +15

Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms

Franco Grimaldi, Nicola Fazio, Roberto Attanasio et al. · Journal of Endocrinological Investigation · 2014 · 22 citations · Full text

Nevirapine restores androgen signaling in hormone‐refractory human prostate carcinoma cells both in vitro and in vivo

Matteo Landriscina, Cinzia Bagalá, Annamaria Piscazzi et al. · The Prostate · 2009 · 21 citations

Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study

Roberta Grande, Filomena Narducci, Sara Bianchetti et al. · Supportive Care in Cancer · 2013 · 17 citations

Medicine, Cutaneous Biology, Phase Ii Study +7

Evaluation of Relapse-Free Survival in T3N0 Colon Cancer: The Role of Chemotherapy, a Multicentric Retrospective Analysis

Roberta Grande, Domenico Corsi, Raffaello Mancini et al. · PLoS ONE · 2013 · 10 citations · Full text